In the context of human intestinal inflammation, the expression of CDC42 is decreased in active IBD, and CDC42 has been suggested as a target of MiR-15a for the regulation of epithelial junctions (ZO1 and E-cadherin) in pediatric patients [156]. The gene discussed is CDC42; the disease is inflammatory bowel disease.